NAVENSI is the sensitive-scalp specialist of the Chinchy Cosmetics family, a house brand built around a single clinical claim: every product is dermatologist-tested and fragrance-free. In a market where 38% of women report some form of scalp sensitivity (contact dermatitis, seborrheic dermatitis, post-chemotherapy, postpartum hormonal shedding), NAVENSI occupies a niche that mass-market shampoo brands have largely ignored. How we formulate for sensitive scalps explains the ingredient philosophy that distinguishes NAVENSI from the other five house brands.
1. Why We Launched a Sensitive-Scalp Brand
In 2019, our R&D team conducted a 600-respondent consumer survey across 12 countries. The top complaint about premium shampoo was not price, fragrance, or sustainability — it was scalp irritation. Yet the entire “premium shampoo” category was built around bold fragrances (rosemary mint, vanilla coconut, citrus bergamot) that are precisely what triggers irritation in sensitive users.
NAVENSI was the response: dermatologist-tested, fragrance-free, sulfate-free, paraben-free, with a pH between 4.5-5.5 to match the scalp’s natural acid mantle. We launched in 2022 with 4 SKUs. Today, NAVENSI is the fastest-growing line in the Chinchy portfolio, with year-over-year growth of 142% in 2025.
2. NAVENSI’s 4 Core SKUs
2.1 NAVENSI Sensitive Scalp Shampoo. 500ml. The flagship. Sulfate-free, fragrance-free, pH 5.0. Suitable for daily use, color-treated hair, and post-chemotherapy clients. Clinically tested on 200 subjects with self-reported scalp sensitivity, 0% adverse reaction rate.
2.2 NAVENSI Hypoallergenic Conditioner. 500ml. Lightweight, does not weigh down fine hair. Same dermatological standards as the shampoo.
2.3 NAVENSI Scalp Soothing Serum. 100ml. Leave-on treatment for acute flare-ups. Contains 2% panthenol + 1% allantoin.
2.4 NAVENSI Fragrance-Free Hair Mask. 500ml. Hydrolyzed oat protein + ceramides. Designed for postpartum hair-loss recovery.
3. The Clinical Testing Protocol Behind NAVENSI
Every NAVENSI SKU passes three rounds of testing before commercial release:
3.1 In-vitro safety. Cytotoxicity testing on reconstructed human epidermis (RhE model) at Guangzhou Medical University.
3.2 Repeat insult patch test (RIPT). 200 subjects, 9 applications over 3 weeks, scored for erythema, edema, and dryness.
3.3 In-use test. 50 subjects with self-reported scalp sensitivity use the product for 4 weeks; 0% drop-out due to irritation is the release threshold.
NAVENSI is one of the few China-made sensitive-scalp lines that has been tested on non-Asian skin types, with 40% of our test panels drawn from European and African subject pools. Regulatory documentation for sensitive-scalp claims lists the certifications we hold for the “dermatologist-tested” label.
4. Target Customers: 4 Segments
NAVENSI is positioned for four specific customer segments:
• Postpartum women experiencing hormonal hair shedding (peak market: 6-12 months after delivery)
• Post-chemotherapy clients in hair regrowth phase
• Contact dermatitis sufferers triggered by fragrance, dyes, or sulfates
• Men 35-55 with seborrheic dermatitis who need daily-use gentle shampoo
5. Where NAVENSI Distributes: 28 Countries
NAVENSI is in 28 countries as of 2025. Top markets: USA, Germany, Switzerland, Japan, South Korea, Singapore, Canada, Australia, UK. The brand has particularly strong uptake in markets with mature dermatologist-prescribed skincare categories (Germany, Japan, South Korea) where consumers expect clinical rigor from “sensitive” labeled products.
6. Distributor Margin & MOQ
NAVENSI distributor margin: 42-48% wholesale. The higher-than-average margin reflects the clinical positioning and the smaller competitor set. MOQ is 500 units per SKU. We strongly recommend distributors carry the full 4-SKU set rather than just the shampoo, because the mask and serum drive the highest reorder frequency.
7. How to Differentiate NAVENSI in Your Market
Three approaches that have worked for our existing distributors:
7.1 Partner with local dermatologists. NAVENSI provides 50 free clinical-trial-size samples per month to distributors who set up sampling programs with local dermatology clinics. In Germany, this drove 38% of new-customer acquisition in 2024.
7.2 Position next to the pharmacy channel. NAVENSI is approved for sale in pharmacy chains (e.g., DocMorris in Germany, Watsons in Asia). Pharmacy placement signals clinical credibility.
7.3 Bundle with scalp-massage tools. The Scalp Soothing Serum sells 2.4× better when bundled with a silicone scalp massager. Distributors in Japan and South Korea have driven 28% basket-size growth with this bundle.
8. Frequently Asked Questions About NAVENSI
Is NAVENSI tested on animals?
No. NAVENSI is certified cruelty-free by Leaping Bunny and PETA. All clinical safety testing uses reconstructed human epidermis models and human volunteer panels.
Does NAVENSI contain any fragrance?
Zero. All NAVENSI products are certified 100% fragrance-free, including no masking fragrances to hide ingredient odor. The product has a neutral, slightly-oat-like scent from the natural ingredients themselves.
Can NAVENSI be used on children?
NAVENSI Sensitive Scalp Shampoo is safe for children 3 years and older. The Scalp Soothing Serum and Hair Mask are formulated for adult use. For children under 3, consult a pediatrician.
How does NAVENSI compare to Vanicream or Free & Clear?
NAVENSI matches the formulation rigor of these US brands but adds hydrolyzed oat protein and ceramides for active hair repair, not just scalp gentleness. In blind panel tests with 100 US consumers who currently use Vanicream, 78% preferred NAVENSI for hair feel after 4 weeks.
